anti-pho- nf-κb p65 monoclonal antibody (Cell Signaling Technology Inc)
Structured Review

Anti Pho Nf κb P65 Monoclonal Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-pho- nf-κb p65 monoclonal antibody/product/Cell Signaling Technology Inc
Average 90 stars, based on 1 article reviews
Images
1) Product Images from "Taraxerone inhibits M1 polarization and alleviates sepsis-induced acute lung injury by activating SIRT1"
Article Title: Taraxerone inhibits M1 polarization and alleviates sepsis-induced acute lung injury by activating SIRT1
Journal: Chinese Medicine
doi: 10.1186/s13020-024-01002-z
Figure Legend Snippet: Primary antibody sources and dilutions
Techniques Used:
Figure Legend Snippet: Taraxerone ameliorates sepsis-induced acute lung injury in mice. Taraxerone (0, 1, 6, and 30 mg/kg) was administered intraperitoneally, and the lung tissues and BALFs were collected 12 h after the CLP model was established. A H&E staining was used to detect histopathological changes in lung tissue. The bar represented 100 μm. B The W/D ratio of lung tissue was measured to determine pneumonedema. C BALFs were collected for total protein content and D count of neutrophils. E The data of breathing frequency and dynamic compliance were detected and collected by BUXCO system. F TNF-α, IL-1β, and IL-6 in BALFs were detected by ELISA. G MPO activity in lung tissue. H The Pho-P65, P65, Pho-IκB, and IκB levels in lung tissues were determined using western blotting. I Schematic diagram of the process of screening M1 macrophages by flow cytometry. J – K The change in M1 macrophage proportion was detected using flow cytometry. Data are presented as mean ± SD (n ≥ 6 in each group). * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001
Techniques Used: Staining, Enzyme-linked Immunosorbent Assay, Activity Assay, Western Blot, Flow Cytometry
Figure Legend Snippet: Taraxerone alleviates LPS-induced inflammatory responses in primary macrophages. A Primary macrophages were exposed to different concentrations of taraxerone (0, 1, 3, 10, 30, and 50 μM) for 12 h, and cell viability was detected with CCK8 kit. Primary macrophages were exposed to different concentrations of taraxerone (10, 30, 50 μM) and LPS (1 μg/mL) for 12 h. B mRNA levels of inflammatory cytokines (IL-1β, IL-6, TNF-α, iNOS, and IL-12) in primary macrophages were detected 12 h later. C P65 nuclear translocation was discovered using immunofluorescence staining. The bar represented 20 μm. D Western blotting was used to determine the location of P65 in the nuclei and cytoplasm. E Western blotting detected Pho-P65, P65, Pho-IκB, and IκB protein levels in primary macrophages. F The M1 macrophage proportion was detected using flow cytometry. Data are presented as mean ± SD (n = 3 in each group). * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001
Techniques Used: Translocation Assay, Immunofluorescence, Staining, Western Blot, Flow Cytometry
Figure Legend Snippet: The anti-inflammatory and anti-oxidative stress effects of taraxerone in primary macrophages are exerted by regulating SIRT1. A Mice were pretreated with taraxerone (1, 6, and 30 mg/kg) or saline for 2 h before cecal ligation and puncture. Primary macrophages were treated with taraxerone (10, 30, and 50 μM) and LPS (1 μg/mL). The protein levels of Ace-P65 were detected using western blotting. B The interaction between SIRT1 and P65 was analyzed using CO-IP. C Western blotting was preformed to determine the effects of taraxerone (50 μM) and EX527 (5 μM/mL) on NLRP3, Cleaved Caspase-1, Pro Caspase-1, ASC, Pho-P65, Ace-P65, P65, Pho-IκB, and IκB protein levels. Primary macrophages were pretreated with EX527 (5 μM/mL) for 2 h, and then treated with LPS (1 μg/mL) and taraxerone (50 μM) for 12 h. D Detection of NLRP3, Pro Caspase-1, ASC, and IL-18 mRNA levels. E The activity of Caspase-1 was measured. F The proportion of CD80 + macrophages was detected using flow cytometry. G , H H2DCFDA probe was used to detect ROS levels. The bar represented 100 μm. I Detection of IL-6, IL-1β, TNF-α, iNOS, and IL-12 mRNA levels. J Detailed view of protein-tar interaction. The SIRT1 residues involved in the interaction are represented by a stick model, where hydrogen bonds are represented by dashed lines. Taraxerone is also represented by a stick model. Data are presented as mean ± SD (n = 6 in vivo, n = 3 in vitro). * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001
Techniques Used: Saline, Ligation, Western Blot, Co-Immunoprecipitation Assay, Activity Assay, Flow Cytometry, In Vivo, In Vitro
Figure Legend Snippet: Taraxerone plays a protective role in sepsis-induced ALI mice through the SIRT1 pathway. The EX527 (10 mg/kg) was administered intraperitoneally 2 h before the taraxerone (0, 30 mg/kg) treatment, and the lung tissues and BALFs were collected after the CLP model was constructed 12 h later. A With H&E staining, we examined the lung tissue for any pathological changes. The bar represented 100 μm. B The breathing frequency and dynamic compliance of mice were detected by BUXCO system. C Detection of IL-1β, IL-6, TNF-α, and IL-18 mRNA levels. D ROS level in BALFs were determined using flow cytometry and analyzed with FlowJo. E Changes in the proportion of M1 macrophages in BALFs were detected using flow cytometry, and the data were analyzed using FlowJo. F Effects of taraxerone (30 mg/kg) and EX527 (10 mg/kg) on NLRP3, Cleaved Caspase-1, Pro Caspase-1, ASC, Pho-P65, Ace-P65, P65, Pho-IκB, and IκB protein levels. G – I MDA content, GSH content, and SOD activity were determined to reflect the oxidative stress levels of lung tissues. Data are presented as mean ± SD (n ≥ 6 in each group). *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001
Techniques Used: Construct, Staining, Flow Cytometry, Activity Assay
Figure Legend Snippet: Taraxerone plays a protective role in acute lung injury by activating SIRT1. Taraxerone activates SIRT1 to block the NF-κB-NLRP3 inflammasome axis and to suppress the excessive ROS, inhibiting the M1 polarization of macrophages, and exerting a protective effect on acute lung injury mice.
Techniques Used: Blocking Assay


